The news on Eisai.Eu

32 days ago

There has been 7 news on Eisai.Eu in the past from 3 different sources and amongst 2 sections.

Full access to all news in this scope:

Eisai eyes fiscal 2025 U.S. approval for home version of Alzheimer's drug

32 days ago

Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says

201 days ago

European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai

209 days ago

Japan's Eisai aims for 2030 U.S. release of new Alzheimer's drug

238 days ago

284 days ago

Eisai seeks expanded use of Alzheimer's drug for prevention

429 days ago

After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen

516 days ago

The coverage spreads amongst 2 sections:

business	14%
health	43%

There has been 3 news sources reporting on this, including: Nikkei (57%), CNBC News (29%), ABC News (14%).

Stay up to date:

This content can be used under the CC BY 4.0 license